| |  Online-Ressource |
|---|
| Verfasst von: | Mohamed, Sherif A. [VerfasserIn]  |
|---|
| | Herrmann, Katrin Elisabeth [VerfasserIn] |
|---|
| | Adlung, Anne [VerfasserIn] |
|---|
| | Paschke, Nadia [VerfasserIn] |
|---|
| | Frölich, Lutz [VerfasserIn] |
|---|
| | Schad, Lothar R. [VerfasserIn] |
|---|
| | Groden, Christoph [VerfasserIn] |
|---|
| | Kerl, Hans Ulrich [VerfasserIn] |
|---|
| Titel: | Evaluation of sodium (23Na) MR-imaging as a biomarker and predictor for neurodegenerative changes in patients with alzheimer’s disease |
|---|
| Verf.angabe: | Sherif A. Mohamed, Katrin Herrmann, Anne Adlung, Nadia Paschke, Lucrezia Hausner, Lutz Frölich, Lothar Schad, Christoph Groden and Hans Ulrich Kerl |
|---|
| E-Jahr: | 2021 |
|---|
| Jahr: | January 2021 |
|---|
| Umfang: | 7 S. |
|---|
| Fussnoten: | Gesehen am 08.04.2021 |
|---|
| Titel Quelle: | Enthalten in: In vivo |
|---|
| Ort Quelle: | Kapandriti, Attiki : IIAR, 2004 |
|---|
| Jahr Quelle: | 2021 |
|---|
| Band/Heft Quelle: | 35(2021), 1, Seite 429-435 |
|---|
| ISSN Quelle: | 1791-7549 |
|---|
| Abstract: | Background/Aim: Sodium (23Na) MR imaging is a noninvasive MRI technique that has been shown to be sensitive to visualize biochemical information about tissue viability, their cell integrity, and cell function in various studies. The aim of this study was to evaluate differences in regional brain 23Na signal intensity between Alzheimer’s disease (AD) and healthy controls to preliminarily evaluate the capability of 23Na imaging as a biomarker for AD. Patients and Methods: A total of 14 patients diagnosed with AD were included: 12 in the state of dementia and 2 with mild cognitive impairment (MCI), and 12 healthy controls (HC); they were all scanned on a 3T clinical scanner with a double tuned 1H/23Na birdcage head coil. After normalizing the signal intensity with that of the vitreous humor, relative tissue sodium concentration (rTSC) was measured after automated segmentation in the hippocampus, amygdala, basal ganglia, white matter (WM) and grey matter (GM) in both cerebral hemispheres. Results: Patients with AD showed a significant increase in rTSC in comparison to healthy controls in the following brain regions: WM 13.6%; p=0.007, hippocampus 12.9%; p=0.003, amygdala 18.9%; p=0.0007. Conclusion: 23Na-MRI has the potential to be developed as a useful biomarker for the diagnosis of AD. |
|---|
| DOI: | doi:10.21873/invivo.12275 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.21873/invivo.12275 |
|---|
| | Volltext: https://iv.iiarjournals.org/content/35/1/429 |
|---|
| | DOI: https://doi.org/10.21873/invivo.12275 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | 23 Na-MRI |
|---|
| | Alzheimer’s disease |
|---|
| | biomarkers |
|---|
| | dementia |
|---|
| | sodium MRI |
|---|
| K10plus-PPN: | 1753348021 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Evaluation of sodium (23Na) MR-imaging as a biomarker and predictor for neurodegenerative changes in patients with alzheimer’s disease / Mohamed, Sherif A. [VerfasserIn]; January 2021 (Online-Ressource)
